Increased flux through the mevalonate pathway mediates fibrotic repair without injury.
Saved in:
| Title: | Increased flux through the mevalonate pathway mediates fibrotic repair without injury. |
|---|---|
| Authors: | Larson-Casey JL; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and., Vaid M; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and., Gu L; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and., He C; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and., Cai GQ; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and., Ding Q; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and., Davis D; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and., Berryhill TF; Targeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama, USA., Wilson LS; Targeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama, USA., Barnes S; Targeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama, USA., Neighbors JD; Department of Medicine, and.; Department of Pharmacology, College of Medicine, Penn State University, Hershey, Pennsylvania, USA.; Penn State Cancer Institute, Hershey, Pennsylvania, USA., Hohl RJ; Department of Medicine, and.; Department of Pharmacology, College of Medicine, Penn State University, Hershey, Pennsylvania, USA.; Penn State Cancer Institute, Hershey, Pennsylvania, USA., Zimmerman KA; Department of Cell, Developmental, and Integrative Biology, and., Yoder BK; Department of Cell, Developmental, and Integrative Biology, and., Longhini ALF; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Hanumanthu VS; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Surolia R; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and., Antony VB; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and., Carter AB; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and.; Birmingham Veterans Administration Medical Center, Birmingham, Alabama, USA. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2019 Nov 01; Vol. 129 (11), pp. 4962-4978. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31609245 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Increased flux through the mevalonate pathway mediates fibrotic repair without injury. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Larson-Casey+JL%22">Larson-Casey JL</searchLink>; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and.<br /><searchLink fieldCode="AU" term="%22Vaid+M%22">Vaid M</searchLink>; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and.<br /><searchLink fieldCode="AU" term="%22Gu+L%22">Gu L</searchLink>; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and.<br /><searchLink fieldCode="AU" term="%22He+C%22">He C</searchLink>; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and.<br /><searchLink fieldCode="AU" term="%22Cai+GQ%22">Cai GQ</searchLink>; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and.<br /><searchLink fieldCode="AU" term="%22Ding+Q%22">Ding Q</searchLink>; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and.<br /><searchLink fieldCode="AU" term="%22Davis+D%22">Davis D</searchLink>; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and.<br /><searchLink fieldCode="AU" term="%22Berryhill+TF%22">Berryhill TF</searchLink>; Targeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Wilson+LS%22">Wilson LS</searchLink>; Targeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Barnes+S%22">Barnes S</searchLink>; Targeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Neighbors+JD%22">Neighbors JD</searchLink>; Department of Medicine, and.; Department of Pharmacology, College of Medicine, Penn State University, Hershey, Pennsylvania, USA.; Penn State Cancer Institute, Hershey, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Hohl+RJ%22">Hohl RJ</searchLink>; Department of Medicine, and.; Department of Pharmacology, College of Medicine, Penn State University, Hershey, Pennsylvania, USA.; Penn State Cancer Institute, Hershey, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Zimmerman+KA%22">Zimmerman KA</searchLink>; Department of Cell, Developmental, and Integrative Biology, and.<br /><searchLink fieldCode="AU" term="%22Yoder+BK%22">Yoder BK</searchLink>; Department of Cell, Developmental, and Integrative Biology, and.<br /><searchLink fieldCode="AU" term="%22Longhini+ALF%22">Longhini ALF</searchLink>; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Hanumanthu+VS%22">Hanumanthu VS</searchLink>; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Surolia+R%22">Surolia R</searchLink>; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and.<br /><searchLink fieldCode="AU" term="%22Antony+VB%22">Antony VB</searchLink>; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and.<br /><searchLink fieldCode="AU" term="%22Carter+AB%22">Carter AB</searchLink>; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, and.; Birmingham Veterans Administration Medical Center, Birmingham, Alabama, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2019 Nov 01; Vol. 129 (11), pp. 4962-4978. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31609245 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1172/JCI127959 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4962 Titles: – TitleFull: Increased flux through the mevalonate pathway mediates fibrotic repair without injury. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Larson-Casey JL – PersonEntity: Name: NameFull: Vaid M – PersonEntity: Name: NameFull: Gu L – PersonEntity: Name: NameFull: He C – PersonEntity: Name: NameFull: Cai GQ – PersonEntity: Name: NameFull: Ding Q – PersonEntity: Name: NameFull: Davis D – PersonEntity: Name: NameFull: Berryhill TF – PersonEntity: Name: NameFull: Wilson LS – PersonEntity: Name: NameFull: Barnes S – PersonEntity: Name: NameFull: Neighbors JD – PersonEntity: Name: NameFull: Hohl RJ – PersonEntity: Name: NameFull: Zimmerman KA – PersonEntity: Name: NameFull: Yoder BK – PersonEntity: Name: NameFull: Longhini ALF – PersonEntity: Name: NameFull: Hanumanthu VS – PersonEntity: Name: NameFull: Surolia R – PersonEntity: Name: NameFull: Antony VB – PersonEntity: Name: NameFull: Carter AB IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2019 Nov 01 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1558-8238 Numbering: – Type: volume Value: 129 – Type: issue Value: 11 Titles: – TitleFull: The Journal of clinical investigation Type: main |
| ResultId | 1 |
